Interim results from a large multinational extension trial (guardian2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

S. R. Lentz, M. Cerqueira, D. Janic, C. Kempton, I. Matytsina, M. Misgav, J. Oldenburg, M. Ozelo, M. Recht, A. Rosholm, A. Savic, T. Suzuki, A. Tiede, E. Santagostino

Research output: Contribution to journalLetter

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)e445-e449
JournalHaemophilia
Volume22
Issue number5
DOIs
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)

Cite this

Lentz, S. R., Cerqueira, M., Janic, D., Kempton, C., Matytsina, I., Misgav, M., Oldenburg, J., Ozelo, M., Recht, M., Rosholm, A., Savic, A., Suzuki, T., Tiede, A., & Santagostino, E. (2016). Interim results from a large multinational extension trial (guardian2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A. Haemophilia, 22(5), e445-e449. https://doi.org/10.1111/hae.12990